| Sign In to gain access to subscriptions and/or personal tools. |
Protective role of the HLA–A*02 allele in Portuguese patients with multiple sclerosisDepartamento de Neurologia, Centro Hospitalar do Porto – Hospital de Santo António, Porto, Portugalanadmsilva{at}yahoo.com
UMIB – Instituto de Ciências Biomédicas Abel Salazar (ICBAS-UP), Porto, Portugal
UMIB – Instituto de Ciências Biomédicas Abel Salazar (ICBAS-UP), Porto, Portugal
Departamento de Neurologia, Centro Hospitalar do Porto – Hospital de Santo António, Porto, Portugal
Unidade de Investigação, Centro de Genética Médica Jacinto de Magalhães, Porto, Portugal
Departamento do estudo de populações, Instituto de Ciências Biomédicas Abel Salazar (ICBAS-UP), Porto, Portugal
UMIB – Instituto de Ciências Biomédicas Abel Salazar (ICBAS-UP), Porto, Portugal; Unidade de Investigação, Centro de Genética Médica Jacinto de Magalhães, Porto, Portugal
Departamento de Neurologia, Centro Hospitalar do Porto – Hospital de Santo António, Porto, Portugal
UMIB – Instituto de Ciências Biomédicas Abel Salazar (ICBAS-UP), Porto, Portugal; Unidade de Investigação, Centro de Genética Médica Jacinto de Magalhães, Porto, Portugal Background Multiple sclerosis (MS) is associated with human leukocyte antigen (HLA) HLA–DRB1*15. Recent evidence that CD8 T cells are implicated in MS suggests that HLA class I may also contribute. An association of HLA–A*02 and A*03 alleles has been described. Objectives We examined the influence of HLA–A*02 and HLA–A*03 in Portuguese patients with MS, independently of HLA–DRB1*15 using a logistic regression model. Conclusions DRB1*15 increased the risk of developing MS and HLA–A*02 decreased the risk. A*03 had no effect. To analyze if HLA–A*02 association was independent from DRB1*15, an interaction between these two alleles was introduced in the model; no significant interaction was found.
Key Words: genetic susceptibility HLA class I multiple sclerosis Portugal
Multiple Sclerosis, Vol. 15, No. 6,
771-774 (2009) |
||||